GROUP ONE TRADING, L.P. - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152W959. A total of 2 filers reported holding AMICUS THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$696,768
+354.7%
57,300
+369.7%
0.00%
Q2 2023$153,232
+4505.7%
12,200
+3966.7%
0.00%
Q1 2023$3,327
-93.4%
300
-92.7%
0.00%
Q4 2022$50,061
-37.4%
4,100
-46.8%
0.00%
Q3 2022$80,000
-44.4%
7,700
-42.5%
0.00%
Q2 2022$144,000
+227.3%
13,400
+191.3%
0.00%
Q1 2022$44,000
-86.9%
4,600
-84.2%
0.00%
Q4 2021$336,000
+26.3%
29,100
+4.3%
0.00%
Q3 2021$266,000
-54.4%
27,900
-53.9%
0.00%
-100.0%
Q2 2021$583,000
-75.7%
60,500
-75.1%
0.00%
-75.0%
Q1 2021$2,399,000
+264.6%
242,800
+751.9%
0.00%
+300.0%
Q4 2020$658,000
+181.2%
28,500
+71.7%
0.00%0.0%
Q3 2020$234,000
-32.6%
16,600
-27.8%
0.00%
-50.0%
Q2 2020$347,000
-43.3%
23,000
-65.3%
0.00%
-60.0%
Q1 2020$612,000
-31.8%
66,200
-28.2%
0.01%
-16.7%
Q4 2019$898,000
+36.9%
92,200
+12.7%
0.01%
+20.0%
Q3 2019$656,000
-47.2%
81,800
-17.9%
0.01%
-54.5%
Q2 2019$1,243,000
+568.3%
99,600
+627.0%
0.01%
+450.0%
Q1 2019$186,000
+177.6%
13,700
+95.7%
0.00%
+100.0%
Q4 2018$67,000
-91.3%
7,000
-89.0%
0.00%
-83.3%
Q3 2018$767,000
-53.3%
63,400
-39.7%
0.01%
-57.1%
Q2 2018$1,643,000
-51.8%
105,200
-53.6%
0.01%
-58.8%
Q1 2018$3,407,000
-64.2%
226,500
-65.7%
0.03%
-49.3%
Q4 2017$9,509,000
-9.1%
660,800
-4.8%
0.07%
-29.5%
Q3 2017$10,466,000
+458.5%
694,000
+272.9%
0.10%
+400.0%
Q2 2017$1,874,000
+3.0%
186,100
-27.1%
0.02%
-9.5%
Q1 2017$1,820,000
-43.7%
255,200
-60.8%
0.02%
-32.3%
Q4 2016$3,235,000
+714.9%
651,000
+1112.3%
0.03%
+675.0%
Q3 2016$397,000
+68.2%
53,700
+24.3%
0.00%
+33.3%
Q2 2016$236,000
-74.2%
43,200
-60.1%
0.00%
-76.9%
Q1 2016$916,000
-76.2%
108,400
-72.7%
0.01%
-71.7%
Q4 2015$3,851,000
-27.8%
397,000
+4.1%
0.05%
-37.8%
Q3 2015$5,333,000
+36.2%
381,200
+37.8%
0.07%
+34.5%
Q2 2015$3,915,000
+49.1%
276,700
+14.7%
0.06%
+34.1%
Q1 2015$2,625,000
+4.9%
241,300
-19.8%
0.04%
+7.9%
Q4 2014$2,503,000
+57.7%
300,800
+12.8%
0.04%
+58.3%
Q3 2014$1,587,000
+214.9%
266,700
+76.9%
0.02%
+200.0%
Q2 2014$504,000
+3500.0%
150,800
+2184.8%
0.01%
Q1 2014$14,000
-12.5%
6,600
-2.9%
0.00%
Q4 2013$16,000
+45.5%
6,800
+38.8%
0.00%
Q3 2013$11,000
-94.5%
4,900
-94.3%
0.00%
-100.0%
Q2 2013$199,00085,3000.01%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,436$2,243,0000.35%
GROUP ONE TRADING, L.P. 105,200$1,643,0000.01%
SIMPLEX TRADING, LLC 756$1,180,0000.01%
JPMORGAN CHASE & CO 40,000$625,0000.00%
View complete list of AMICUS THERAPEUTICS INC shareholders